Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does lipitor alcohol interaction cause side effects?What factors influence tigecycline's success in combined treatments?What tests are used to diagnose lipitor induced liver damage?Is it true multivitamins boost lipitor's potency?How does temperature affect lurbinectedin degradation?
See the DrugPatentWatch profile for tigecycline
How often does tigecycline use result in severe diarrhea? Tigecycline causes diarrhea in about 12% of patients, but severe cases are rare. Clinical reports show that most diarrhea cases remain mild to moderate and resolve without stopping treatment. How common is C. diff infection after tigecycline? Tigecycline disrupts gut bacteria and raises the risk of Clostridioides difficile (C. diff) infection, which can produce severe diarrhea. Reports vary from 0.3% to 2% across studies. The company’s own safety data recorded one case of pseudomembranous colitis in 2,400 patients. What happens if severe diarrhea develops during tigecycline treatment? Patients should stop taking the drug and seek medical care if they develop severe, persistent diarrhea during or after tigecycline use. Doctors usually test for C. diff toxin and may treat the infection with oral vancomycin or fidaxomicin. Can other antibiotics replace tigecycline if diarrhea becomes a problem? Yes. Alternatives such as linezolid, daptomycin, or meropenem provide coverage for similar bacteria without the same strong gut disruption. Doctors choose replacements based on susceptibility testing and patient-specific risks. How does tigecycline’s safety profile compare with other tetracyclines? Tigecycline belongs to the glycylcycline class and has a broader spectrum and larger disruption of normal gut flora than older tetracyclines. This explains why its diarrhea rate is higher than conditions like doxycycline, but similar or higher than some broad-spectrum antibiotics. When does tigecycline’s patent expire? Tigecycline’s composition-of-matter patent expired in 2016. The last remaining data exclusivity ended in 2017. Generics entered the U.S. market in 2018.
Other Questions About Tigecycline :